Floatz logo

Therapeutic Asset Ratings

1,482 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
PROPRANOLOL
Intracerebral Hemorrhage
Tang-Du HospitalP2/3B (62)
Recombinant Human Hyaluronidase
High Grade B-Cell Lymphoma
University of WashingtonP2/3B (62)
Recombinant Human Hyaluronidase
Nodular Lymphocyte Predominant Hodgkin Lymphoma
National Cancer Institute (NCI)P2/3B (62)
Recombinant Human Tissue Kallikrein
Stroke Disorder
DiaMedica Therapeutics IncP2/3B (62)
Relatlimab
Urinary Bladder Carcinoma
National Cancer Institute (NCI)P2/3B (62)
Relatlimab
Renal Pelvis Urothelial Carcinoma
National Cancer Institute (NCI)P2/3B (62)
Ruxolitinib
Acute Lymphoblastic Leukemia
Bambino Gesù Hospital and Research InstituteP2/3B (62)
Ruxolitinib
Lymphoblastic Lymphoma
St. Petersburg State Pavlov Medical UniversityP2/3B (62)
Ruxolitinib
Childhood Acute Myeloid Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP2/3B (62)
Selinexor
Peripheral T-Cell Lymphoma, Not Otherwise Specified
The First Hospital of Jilin UniversityP2/3B (62)
Sorafenib
Acute Monocytic Leukemia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP2/3B (62)
Sotrovimab
COVID-19
Fred Hutchinson Cancer CenterP2/3B (62)
TAMOXIFEN
Breast Disorder
Fujian Cancer HospitalP2/3B (62)
TAMOXIFEN
Cancer
Merck Sharp & Dohme LLCP2/3B (62)
TRASTUZUMAB
Lung Neoplasm
Cancer Research UKP2/3B (62)
Tucidinostat
Acute Leukemia
The First Affiliated Hospital of Soochow UniversityP2/3B (62)
UREA, N-(2-CHLOROETHYL)-N'-(4-METHYLCYCLOHEXYL)-N-NITROSO-
Allogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow UniversityP2/3B (62)
VEMURAFENIB
Hematopoietic And Lymphoid System Neoplasm
Cancer Research UKP2/3B (62)
Venetoclax
B-Cell Acute Lymphoblastic Leukemia
City of Hope Medical CenterP2/3B (62)
Venetoclax
Large B-Cell Lymphoma
Ruijin HospitalP2/3B (62)
Venetoclax
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
National Cancer Institute (NCI)P2/3B (62)
Venetoclax
T Lymphoblastic Leukemia/Lymphoma
Princess Maxima Center for Pediatric OncologyP2/3B (62)
(+)-VINCRISTINE
Acute Leukemia
SWOG Cancer Research NetworkP2/3B (62)
(+)-VINCRISTINE
Recurrent Primary Peritoneal Endometrioid Adenocarcinoma
Roswell Park Cancer InstituteP2/3B (62)
VINCRISTINE SULFATE
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3B (62)
Showing 376 to 400 of 1,482 assets
PreviousPage 16 of 60Next